is glp-1 good for you How Do Injections Help with Medical Weight Loss? Your guide to GLP-1 side

Serious psychiatric diseases like depression and anxiety were rare across all groups

The Medicinal product is a whole thing and it's a living cosmetics

How Retatrutide Compares to Existing Therapies The progression from single to dual to triple agonist therapy represents a clear trend in obesity pharmacotherapy: Semaglutide (GLP-1 agonist): ~1517% weight loss in Phase III (STEP trials) Tirzepatide (GIP + GLP-1 dual agonist): ~2022.5% weight loss in Phase III (SURMOUNT trials) Retatrutide (GIP + GLP-1 + glucagon triple agonist): ~2629% weight loss in Phase III (TRIUMPH-4) Each additional receptor pathway appears to contribute incremental efficacy

doi: 10.1007/BF00054162

It is generally regarded as the most painful venom produced by any vertebrate